Codrituzumab
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1365267-33-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1194333-01 0.02 mg (E-Coli)
Recombinant Synechocystis sp. UPF0012 hydrolase sll0601 (sll0601)
Ask
View Details MBS1194333-02 0.02 mg (Yeast)
Recombinant Synechocystis sp. UPF0012 hydrolase sll0601 (sll0601)
Ask
View Details MBS1194333-03 0.1 mg (E-Coli)
Recombinant Synechocystis sp. UPF0012 hydrolase sll0601 (sll0601)
Ask
View Details